CompletedNCT01081418
Assertive community treatment with integrated care for schizophrenia
About this title
Read the official source — NCT01081418Behavioural studyAges 18–65Germany
Understand this study
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- HamburgSee all locations and recruitment
Study information
Study start dateApril 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 120
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Germany
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01081418
- Official title
Show the full official title
Assertive Community Treatment (ACT) as Part of Integrated Care Versus Standard Care: a 12-month Trial in Patients With First- and Negatively Selected Multiple-episode Schizophrenia-spectrum Disorders Treated With Quetiapine IR
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hamburg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Universitätsklinikum Hamburg-Eppendorf.
Who was this study for?
This study was for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
Want to explore more studies?
Explore studiesRelated studies
A comparison study of fish oil capsules and psychological therapy versus placebo capsules and psychological therapy in patients at risk of developing a psychotic disorder.
Shared decision-making training for inpatients with schizophrenia